Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18997681 | 0.85 | CACNA1F (0.35) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL438988 | 0.78 | — | — | |
| SCHEMBL7775143 | 0.78 | — | — | |
| SCHEMBL6200856 | 0.78 | — | — | |
| SCHEMBL7775114 | 0.76 | CACNA1F (0.39) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL12403740 | 0.76 | DPP4 (0.32) | DPP4 | |
| SCHEMBL14176514 | 0.76 | CACNA1F (0.39) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL24191897 | 0.75 | CACNA1F (0.35) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL24191896 | 0.75 | CACNA1F (0.35) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL24191892 | 0.75 | CACNA1F (0.35) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4405581-A | Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-09-20 | — | — | US | claimed |
| US-12427472-B2 | Process for removal of acid gases from a fluid stream | BASF SE (DE) | 2025-09-30 | — | — | US | disclosed |
| CN-114173908-B | Method for removing acid gases from fluid streams | 巴斯夫欧洲公司 | 2025-04-01 | — | — | CN | disclosed |
| WO-2025038904-A2 | REDUCING CONSUMPTION OF SULFIDING AGENT IN HYDROPROCESSING OF BIOFEEDSTOCKS | ExxonMobil Technology and Engineering Company (US) | 2025-02-20 | — | — | WO | disclosed |
| US-12138583-B2 | Process for removal of acid gases from a fluid stream with a liquid absorbent comprising a piperazine ring | BASF SE (DE) | 2024-11-12 | — | — | US | disclosed |
| CN-113453784-B | Method for removing acid gases from fluid streams | 巴斯夫欧洲公司 | 2024-09-13 | — | — | CN | disclosed |
| US-20240042375-A1 | PROCESS FOR REMOVAL OF ACID GASES FROM A FLUID STREAM | BASF SE (DE) | 2024-02-08 | — | — | US | disclosed |
| EP-4028148-B1 | PROCESS FOR REMOVAL OF ACID GASES FROM A FLUID STREAM | BASF SE (DE) | 2023-11-15 | — | — | EP | disclosed |
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | SHY Therapeutics LLC | 2023-09-14 | — | — | US | disclosed |
| EP-3927450-B1 | PROCESS FOR REMOVAL OF ACID GASES FROM A FLUID STREAM WITH A LIQUID ABSORBENT COMPRISING A PIPERAZINE RING | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
| EP-2825286-A1 | AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES | ExxonMobil Research and Engineering Company (US) | 2015-01-21 | — | — | EP | disclosed |
| CN-104284706-A | Amine treatment process for separating acid gases using mixtures of amines and alkoxyamines | EXXON MOBIL RES & ENG CO | 2015-01-14 | — | — | CN | disclosed |
| US-20130243676-A1 | AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-09-19 | — | — | US | disclosed |
| WO-2013138443-A1 | AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-09-19 | — | — | WO | disclosed |
| US-20110202328-A1 | System for the determination of selective absorbent molecules through predictive correlations | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110202328-A1 | System for the determination of selective absorbent molecules through predictive correlations | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-08-18 | — | — | US | disclosed |
| WO-1993010883-A1 | LEAN ACID GAS ENRICHMENT WITH SELECTIVE HINDERED AMINES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1993-06-10 | — | — | WO | disclosed |
| US-4405581-A | Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-09-20 | — | — | US | disclosed |
| EP-0087208-A1 | A process for removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427472-B2 | Process for removal of acid gases from a fluid stream | C5, C1S, C9 | CACNA1F 2995/4885CHRM2 224/4885CHRM1 133/4885 |
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | MAPK6, MAP3K6, MAPK4 | CACNA1F 4878/4885CHRM2 4708/4885CHRM1 4749/4885 |
| US-20240042375-A1 | PROCESS FOR REMOVAL OF ACID GASES FROM A FLUID STREAM | C5, C1S, C9 | CACNA1F 2995/4885CHRM2 224/4885CHRM1 133/4885 |
| US-12138583-B2 | Process for removal of acid gases from a fluid stream with a liquid absorbent comprising a piperazine ring | AVPR2, HRH2, SLC43A1 | CACNA1F 2044/4885CHRM2 38/4885CHRM1 55/4885 |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | CACNA1F 4878/4885CHRM2 4708/4885CHRM1 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.